Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

This Block Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday

Author: Avi Kapoor | August 05, 2025 09:11am

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

  • Keybanc analyst Brett Fishbin downgraded Inspire Medical Systems, Inc. (NYSE:INSP) from Overweight to Sector Weight. Inspire Medical Systems shares closed at $129.95 on Monday. See how other analysts view this stock.
  • Jefferies analyst Roger Song downgraded LAVA Therapeutics N.V. (NASDAQ:LVTX) from Buy to Hold and lowered the price target from $3 to $1.5. LAVA Therapeutics shares closed at $1.47 on Monday. See how other analysts view this stock.
  • JP Morgan analyst Detlef Winckelmann downgraded International Paper Company (NYSE:IP) from Overweight to Neutral and cut the price target from $55 to $54. International Paper shares closed at $46.06 on Monday. See how other analysts view this stock.
  • UBS analyst Matthew Weston downgraded the rating for Novo Nordisk A/S (NYSE:NVO) from Buy to Neutral. Novo Nordisk shares closed at $48.81 on Monday. See how other analysts view this stock.
  • Morgan Stanley analyst James Faucette downgraded Block, Inc. (NYSE:XYZ) from Overweight to Equal-Weight and maintained the price target of $73. Block shares closed at $76.12 on Monday. See how other analysts view this stock.

Considering buying XYZ stock? Here’s what analysts think:

Read This Next:

Photo via Shutterstock

Posted In: INSP IP LVTX NVO XYZ

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist